<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cancerci.com/feeds/articlecomments?arxId=1475-2867-5-34&amp;format=rss&amp;version=&amp;quantity=">
        <title>Article Comments - 'Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer'</title>
        <link>http://www.cancerci.com/content/5/1/34/comments</link>
        <description>The latest comments on the article 'Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer'</description>
        <dc:date>2005-12-21T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://www.cancerci.com/content/5/1/34" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cancerci.com/content/5/1/34/comments#218502">
        <title>Mitochondrial Bed-Side Evaluation: a new Way in the War against Cancer.</title>
        <link>http://www.cancerci.com/content/5/1/34/comments#218502</link>
        <description>&lt;p&gt;I agree with the autors&amp;#8217;s conclusions of this interesting paper (Himani Sharma, Archna Singh, et al. Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer Cancer Cell International 2005, 5:34     doi:10.1186/1475-2867-5-34). In fact, in previous articles,  I referred that, as a working hypothesis, I thought a long time ago that all chromosomal alterations, of whatever nature, both n-DNA and m-DNA, are necessarily accompanied with similar microvascular modification of the local microcirculatory bed, both structural and functional in nature, in subjects involved by abnormalities of pschyco-neuro-endocrinological-immune system, i.e., in malignancy biological control system, I defined as  Oncological Terrain (1-6). Really, both genetical and environmental factors induce contemporaneously parenchymal and microvascular cells alterations, according to the well-known concept of Tiscendorf&amp;#8217;s Angiobiotopie, I completed with Angiobiopathy  new concept (1). In a few words, all oncological cell-dependent events (control, regulation, duplication, a.s.o.), may happen only by means of singular changes in local structural and functional microcirculation, which notoriously supplies information-material-energy to related tissue cells (See my web sites  http://www.semeioticabiofisica.it and http://www.semeioticabiofisica.it/microangiologia.it).  Now-a-days, thanks to Biophysical Semeiotics, we can fortunately evaluate clinically microcirculatory bed structure and function in a precise manner, e.g., of breast cancer real risk, and cancer, of course, of all other biological systems, including lymphnodes and bone-marrow, assessing clinically local vasomotility and vasomotion (1-6). Evaluating properly the type of microcirculatory activation of cancer as well as of local lymphnodes and bone-marrow (type I, associated, physiological; type II, intermediate, partially dissociated, characteristic of real oncological risk, and finally type III, dissociated, indicating cancer onset) we can evaluate in a quantitative way the alterations of physiological relation between vasomotility (= chaotic deterministic oscillations of small arterioles and arterioles, according to Hammersen, on the one hand, and vasomotion (= chaotic deterministic oscillations of related capillary and post-capillary primary venules), since the intensity of such as dissociation is correlated with the seriousness of underlying oncological disorders. &lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt;1) Stagnaro Sergio, Stagnaro-Neri Marina. Introduzione alla Semeiotica Biofisica. Il Terreno oncologic. Travel Factory SRL., Roma, 2004. &lt;/p&gt;&lt;p&gt;http://www.travelfactory.it/semeiotica_biofisica.htm&lt;/p&gt;&lt;p&gt;2) Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ediz. Travel Factory, Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica.htm &lt;/p&gt;&lt;p&gt;3) Stagnaro-Neri M., Moscatelli G. Stagnaro S., Biophysical Semeiotics: deterministic Chaos and biological Systems. Gazz. Med. It. Arch. Sc. Med. 155, 125 ,1996 &lt;/p&gt;&lt;p&gt;4) Stagnaro Sergio.  &quot;Genes, Oncological Terrain, and Breast Cancer&quot; World Journal of  Surgical Oncology., 2005, http://www.wjso.com/content/3/1/45/comments#205475&lt;/p&gt;&lt;p&gt;5) Stagnaro  Sergio. Relevance of Mitochondria in Cancerogenesis. Journal of Carcinogenesis. 2005, 4:1     doi:10.1186/1477-3163-4-1http://www.carcinogenesis.com/content/4/1/1/comments#136454&lt;/p&gt;&lt;p&gt;6) Stagnaro  Sergio. Bed-Side Evaluating Breast Cancer Real Risk.  World Journal of Surgical Oncology. 2005, 3:67     doi:10.1186/1477-7819-3-67. 2005&lt;/p&gt;</description>
                <dc:creator>Sergio Stagnaro</dc:creator>
                <dc:date>2005-12-21T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
